Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia.

K Lin, M Farahani, Y Yang, GG Johnson, M Oates, M Atherton, A Douglas, N Kalakonda, AR Pettitt

Research output: Contribution to JournalArticlepeer-review

Fingerprint

Dive into the research topics of 'Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia.'. Together they form a unique fingerprint.

Medicine & Life Sciences